MANDY MIRANDA: Open Payments
NPI 1801472824 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,937 in 131 payments from 35 companies in 2025. Trend: 2023 $890 · 2024 $1,225 · 2025 $2,937
Food & beverage: $2,638Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $325 |
| Merck Sharp & Dohme LLC | 12 | $247 |
| Incyte Corporation | 12 | $234 |
| PFIZER INC. | 12 | $229 |
| Gilead Sciences, Inc. | 6 | $211 |
| Novartis Pharmaceuticals Corporation | 8 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Eisai Inc. | 8 | $138 |
| SEAGEN INC. | 1 | $99 |
| GENZYME CORPORATION | 3 | $99 |
Products named: KEYTRUDA, Trodelvy, MONJUVI, Lenvima, KISQALI, IBRANCE, DARZALEX, SARCLISA.
Industry payments across FL — which companies pay providers there.
